Sign In
Buy ARMP
$7.01
+0.140 (+2.04%)
At Close: Jun 23, 2026
Larry Fink's 2020 Letter To Shareholders
01:35pm, Tuesday, 31'st Mar 2020
The outbreak has impacted financial markets with a swiftness and ferocity normally seen only in a classic financial crisis. As clients seek to adjust their port
Armata Pharmaceuticals Announces Closing of Second Tranche of $25 Million Securities Purchase Agreement with Innoviva, Inc.
11:30am, Monday, 30'th Mar 2020
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, to
Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Results and Provides General Corporate Update
08:05pm, Thursday, 19'th Mar 2020
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant
Armata Pharmaceuticals (ARMP) Gets a Buy Rating from Maxim Group
01:42pm, Thursday, 19'th Mar 2020
In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Armata Pharmaceuticals (ARMP), with a price target of $8.00. The
Armata Pharmaceuticals Announces up to $5 Million Therapeutics Development Award from the Cystic Fibrosis Foundation
12:00pm, Wednesday, 18'th Mar 2020
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced tha
Gig workers do not need to stop working in California
11:40pm, Monday, 16'th Mar 2020
Gig workers are being excluded from the stop working/ shelter-in-place announcement just made for the Bay Area, according to the new public health order,
Fed cuts interest rates by half percentage point in rare inter-meeting move
08:46pm, Tuesday, 03'rd Mar 2020
The Federal Reserve, in a rare inter-meeting move, on Tuesday cut its benchmark interest rate to counter the threat to the economy from the coronavirus...
La difficile et lente conversion en bio des éleveurs de porcs
06:53am, Friday, 21'st Feb 2020
A peine 1% de la viande porcine produite en France est bio. La filière éprouve beaucoup de difficultés à se convertir. Pourtant, ce bouleversement du mode de production semble profitable.
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, to
Bud Light makes a move into hard seltzer just in time for Super Bowl 2020
07:12pm, Saturday, 01'st Feb 2020
Bud Light says its strawberry hard seltzer goes great with cheesecake.
Thunderstruck Drills 13.8 Percent Zinc, 2.94 Percent Copper over 11 Metres at its Korokayiu Copper-Zinc VMS Prospect | INN
10:31pm, Thursday, 30'th Jan 2020
Results prompt Company to increase land position from 30 to 136 square kilometres
Armata investment removes significant overhang, says H.C. Wainwright ARMP;INVA
02:24pm, Wednesday, 29'th Jan 2020
Armata investment removes significant overhang, says H.C. Wainwright H.C. Wainwright ARMP INVA
Company News For Jan 29, 2020
01:04pm, Wednesday, 29'th Jan 2020
Companies In The News Are: ARMP, GGG, MMM and OBCI
70 Biggest Movers From Yesterday
09:40am, Wednesday, 29'th Jan 2020
Gainers
Armata Pharmaceuticals, Inc. (NYSE: ARMP) shares surged 77.1% to close at $4.94 on Tuesday. Armata Pharmaceuticals and Innoviva reported a $25 million strategic...
